Latest Sales Growth News

OMG Group Limited has reported record monthly sales of $602,000 in June 2025, driven by surging ecommerce demand and strong operational cashflow, positioning the company for continued growth in FY26.

Oceania Holdings Limited showcased robust operational progress and a strategic pivot towards portfolio modernization at its 2025 Annual Meeting, while announcing a new cost savings program and withholding its final dividend for FY25.

Oceania Healthcare’s CEO delivered a confident first AGM address highlighting robust sales growth, operational efficiencies, and a refreshed strategic vision focused on care quality and sustainability.

Orthocell has marked a pivotal milestone with the first US surgical use of its Remplir™ nerve repair device following FDA clearance, setting the stage for commercial expansion in a $1.6 billion market.

Collins Foods delivered resilient FY25 results with solid revenue growth and a strategic pivot towards German market expansion, while addressing profitability challenges in the Netherlands.

Collins Foods reported a record $1.52 billion revenue for FY25 with flat EBITDA despite tough market conditions, while signaling optimism for low to mid-teens NPAT growth in FY26.

Adairs Limited projects modest overall growth for FY25, buoyed by strong performances from Adairs and Mocka brands, while Focus on Furniture struggles with declining sales and earnings.

Metcash Limited reported solid FY25 financial results with revenue growth and market share gains across key pillars, underpinned by strategic acquisitions and operational improvements. The company enters FY26 with positive momentum and ongoing transformation initiatives.

Hydralyte USA reported its strongest monthly sales in May 2025, alongside continued improvement in EBITDA losses, signaling steady progress toward profitability.

KMD Brands reports mixed sales across its portfolio with a notable rebound in Kathmandu’s direct-to-consumer sales and robust online growth, while managing tariff uncertainties and margin pressures.

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

Cettire Limited reports a slight 1.7% increase in sales revenue for the year-to-date FY25 amid ongoing global luxury market challenges, including US tariff impacts and volatile demand. The company focuses on emerging markets expansion and improving profitability despite margin pressures.